Material Safety Data Sheet Cadmium Sulfate Octahydrate ACC# 03810 Section 1 - Chemical Product and Company Identification
Total Page:16
File Type:pdf, Size:1020Kb
Material Safety Data Sheet Cadmium Sulfate Octahydrate ACC# 03810 Section 1 - Chemical Product and Company Identification MSDS Name: Cadmium Sulfate Octahydrate Catalog Numbers: C19 500, C19-100, C19-500, C19100, C19500 Synonyms: Cadmium sulphate octahydrate; sulfuric acid cadmium salt octahydrate Company Identification: Fisher Scientific 1 Reagent Lane Fair Lawn, NJ 07410 For information, call: 201-796-7100 Emergency Number: 201-796-7100 For CHEMTREC assistance, call: 800-424-9300 For International CHEMTREC assistance, call: 703-527-3887 Section 2 - Composition, Information on Ingredients CAS# Chemical Name Percent EINECS/ELINCS 7790-84-3 Cadmium Sulfate Octahydrate 100 unlisted Section 3 - Hazards Identification EMERGENCY OVERVIEW Appearance: white solid. Danger! Danger of serious damage to health by prolonged exposure through inhalation and if swallowed. Cancer hazard. Carcinogen. Harmful if swallowed. Causes eye and skin irritation. Contains cadmium. Avoid creating dust. Causes digestive and respiratory tract irritation. May cause lung damage. May cause liver and kidney damage. Target Organs: Kidneys, liver, lungs, skeletal structures. Potential Health Effects Eye: Causes eye irritation. Skin: Causes skin irritation. May be harmful if absorbed through the skin. Ingestion: Harmful if swallowed. Causes gastrointestinal irritation with nausea, vomiting and diarrhea. May cause unconsciousness. Inhalation: Effects may be delayed. Causes respiratory tract irritation. Irritation may lead to chemical pneumonitis and pulmonary edema. May cause dyspnea (difficult or labored breathing). May cause cough, chest pain, fever, muscular cramps, and headache. Chronic: May cause respiratory tract cancer. Prolonged or repeated exposure may cause permanent bone structure abnormalities. May cause liver and kidney damage. May cause anemia and other blood cell abnormalities. Chronic inhalation may cause pulmonary emphysema. Chronic inhalation may cause pulmonary fibrosis. Inhalation of dust may cause chronic rhinitis (inflammation of the mucous membrane of the nose). Section 4 - First Aid Measures Eyes: Immediately flush eyes with plenty of water for at least 15 minutes, occasionally lifting the upper and lower eyelids. Get medical aid imme diately. Skin: Get medical aid immediately. Immediately flush skin with plenty of water for at least 15 minutes while removing contaminated clothing and shoes. Ingestion: Call a poison control center. If swallowed, do not induce vomiting unless directed to do so by medical personnel. Never give anything by mouth to an unconscious person. Get medical aid. Inhalation: Get medical aid immediately. Remove from exposure and move to fresh air immediately. If not breathing, give artificial respiration. If breathing is difficult, give oxygen. Notes to Physician: Treat symptomatically and supportively. Antidote: The use of Calcium disodium EDTA as a chelating agent should be determined by qualified medical personnel. Section 5 - Fire Fighting Measures General Information: As in any fire, wear a self-contained breathing apparatus in pressure-demand, MSHA/NIOSH (approved or equivalent), and full protective gear. During a fire, irritating and highly toxic gases may be generated by thermal decomposition or combustion. Extinguishing Media: Substance is noncombustible; use agent most appropriate to extinguish surrounding fire. Flash Point: Not applicable. Autoignition Temperature: Not applicable. Explosion Limits, Lower:Not available. Upper: Not available. NFPA Rating: (estimated) Health: 2; Flammability: 0; Instability: 0 Section 6 - Accidental Release Measures General Information: Use proper personal protective equipment as indicated in Section 8. Spills/Leaks: Vacuum or sweep up material and place into a suitable disposal container. Clean up spills immediately, observing precautions in the Protective Equipment section. Avoid generating dusty conditions. Provide ventilation. Section 7 - Handling and Storage Handling: Wash hands before eating. Minimize dust generation and accumulation. Do not breathe dust, vapor, mist, or gas. Do not get in eyes, on skin, or on clothing. Do not ingest or inhale. Use only in a chemical fume hood. Storage: Store in a cool, dry place. Store in a tightly closed container. Section 8 - Exposure Controls, Personal Protection Engineering Controls: Facilities storing or utilizing this material should be equipped with an eyewash facility and a safety shower. Use adequate general or local exhaust ventilation to keep airborne concentrations below the permissible exposure limits. Exposure Limits Chemical Name ACGIH NIOSH OSHA - Final PELs 2.5 æg/m3 Action Level (as Cd); 5 æg/m3 PEL (as Cd. Do not eat, 0.01 mg/m3 TWA (as Cd); 0.002 drink or chew t obacco or gum or mg/m3 TWA (respirable fraction, as apply cosmetics in regulated areas. Cadmium Sulfate Octahydrate Cd) (listed under Cadmium none listed Carcinogen: dust can cause lung compounds). and kidney disease. See 29 CFR 1910.1027) (listed under Cadmium compounds). 2.5 æg/m3 Action Level (as Cd); 5 æg/m3 PEL (as Cd. Do not eat, 0.01 mg/m3 TWA (as Cd); 0.002 drink or chew t obacco or gum or mg/m3 TWA (respirable fraction, as apply cosmetics in regulated areas. Cadmium sulfate Cd) (listed under Cadmium none listed Carcinogen: dust can cause lung compounds). and kidney disease. See 29 CFR 1910.1027) (listed under Cadmium compounds). OSHA Vacated PELs: Cadmium Sulfate Octahydrate: No OSHA Vacated PELs are listed for this chemical. Cadmium sulfate: No OSHA Vacated PELs are listed for this chemical. Personal Protective Equipment Eyes: Wear appropriate protective eyeglasses or chemical safety goggles as described by OSHA's eye and face protection regulations in 29 CFR 1910.133 or European Standard EN166. Skin: Wear appropriate protective gloves and clothing to prevent skin exposure. Clothing: Wear appropriate protective clothing to prevent skin exposure. Respirators: Follow the OSHA respirator regulations found in 29 CFR 1910.134 or European Standard EN 149. Use a NIOSH/MSHA or European Standard EN 149 approved respirator if exposure limits are exceeded or if irritation or other symptoms are experienced. Section 9 - Physical and Chemical Properties Physical State: Solid Appearance: white Odor: none reported pH: Not available. Vapor Pressure: Negligible. Vapor Density: Not applicable. Evaporation Rate:Negligible. Viscosity: Not applicable. Boiling Point: Not available. Freezing/Melting Point:126 deg F Decomposition Temperature:Not available. Solubility: Soluble in water. Specific Gravity/Density:3.09 (water=1) Molecular Formula:(CdSO4)3.8H2O Molecular Weight:769.51 Section 10 - Stability and Reactivity Chemical Stability: Stable. Conditions to Avoid: Incompatible materials, dust generation. Incompatibilities with Other Materials: Metals, oxidizing agents, zinc, selenium, tellurium, hydrogen azide, Violently reacts with magnesium and with aluminum powder when heated.. Hazardous Decomposition Products: Oxides of sulfur, toxic cadmium oxide fumes. Hazardous Polymerization: Has not been reported. Section 11 - Toxicological Information RTECS#: CAS# 7790-84-3: EV2850000 CAS# 10124-36-4: EV2700000 LD50/LC50: Not available. CAS# 10124-36-4: Oral, mouse: LD50 = 47 mg/kg; Oral, rat: LD50 = 280 mg/kg; . Carcinogenicity: CAS# 7790-84-3: ACGIH: A2 - Suspected Human Carcinogen (listed as 'Cadmium compounds'). California: carcinogen, initial date 10/1/87 (listed as Cadmium compounds). NTP: Known carcinogen (listed as Cadmium compounds). IARC: Group 1 carcinogen (listed as Cadmium compounds). CAS# 10124-36-4: ACGIH: A2 - Suspected Human Carcinogen (listed as 'Cadmium compounds'). California: carcinogen, initial date 10/1/87 (listed as Cadmium compounds). NTP: Known carcinogen (listed as Cadmium compounds). IARC: Group 1 carcinogen (listed as Cadmium compounds). Epidemiology: NIOSH cited recent epidemiological evidence of a significant excess of respiratory cancer deaths among a cohort of cadmium production workers, and concluded that cadmium and its compounds are potential carcinogens. Teratogenicity: Experimental teratogenic effects have been reported. Reproductive Effects: Experimental reproductive effects have been reported. Mutagenicity: Mutagenic effects have occurred in experimental animals. Neurotoxicity: No information found Other Studies: Section 12 - Ecological Information No information available. Section 13 - Disposal Considerations Chemical waste generators must determine whether a discarded chemical is classified as a hazardous waste. US EPA guidelines for the classification determination are listed in 40 CFR Parts 261.3. Additionally, waste generators must consult state and local hazardous waste regulations to ensure complete and accurate classification. RCRA P-Series: None listed. RCRA U-Series: None listed. Section 14 - Transport Information US DOT Canada TDG Shipping Name: CADMIUM COMPOUNDS CADMIUM COMPOUND (CADMIUM SULFATE) Hazard Class: 6.1 6.1 UN Number: UN2570 UN2570 Packing Group: III III Section 15 - Regulatory Information US FEDERAL TSCA CAS# 7790-84-3 is not listed on the TSCA inventory. It is for research and development use only. CAS# 10124-36-4 is listed on the TSCA inventory. Health & Safety Reporting List None of the chemicals are on the Health & Safety Reporting List. Chemical Test Rules None of the chemicals in this product are under a Chemical Test Rule. Section 12b None of the chemicals are listed under TSCA Section 12b. TSCA Significant New Use Rule None of the chemicals in this material have a SNUR under TSCA. CERCLA Hazardous Substances